Complete/near complete occlusion at 3 months | 56.0 (31.0 to 79.0) | 37/76 | 45.0 (22.0 to 71.0) | 59/109 | 0.56 |
Improvement in mass effect | 44.0 (26.0 to 64.0) | 13/28 | 75.0 (49.0 to 90.0) | 61/75 | 0.06 |
Retreatment rate | 22.0 (14.0 to 33.0) | 15/74 | 20.0 (12.0 to 31.0) | 21/152 | 0.80 |
Total periprocedural morbidity | 0.0 (0.0 to 21.0) | 0/74 | 4.0 (2.0 to 9.0) | 1/152 | 0.68 |
Periprocedural stroke | 0.0 (0.0 to 21.0) | 0/74 | 0.0 (0.0 to 9.0) | 0/152 | 0.56 |
Periprocedural hemorrhage | 0.0 (0.0 to 21.0) | 0/74 | 4.0 (2.0 to 9.0) | 1/152 | 0.68 |
Periprocedural mortality | 0.0 (0.0 to 18.0) | 0/74 | 0.0 (0.0 to 9.0) | 0/152 | 0.56 |